Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

For people with anxiety and depression, these conditions can feel like two sides of the same coin. Researchers are exploring ...

The synergistic relationship between psychiatric medications and psychotherapy is often overlooked. By managing discreet ...

After getting a metastatic breast cancer diagnosis, you may experience anxiety and depression. Here are some ways to manage ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

CIII nasal spray, marking the first monotherapy to be approved for adults with treatment-resistant depression (TRD).

Emerging research in mental health is showing how little we know and thus how much work needs to be done, including in how ...

If you’ve been diagnosed with major depressive disorder or a form of anxiety, your mental health provider may prescribe the ...

The U.S. Food and Drug Administration ( FDA) has approved the use of a nasal spray as a standalone treatment for major depressive disorder, offering a new option for those struggling with ...

The TGA has issued a requirement for new warnings to be provided with the drug montelukast, commonly used to treat asthma and ...

When children with obesity undergo weight-loss treatment, the effects have repercussions later in life and the risk of serious health problems and premature death is lower as they reach young ...